Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • August 2002 | Volume 15 - Issue 8
    By Jeff Hall, Editor-in-Chief
    2,268 reads | 0 comments | 08/03/02
    My sister gave me a wonderful Christmas present a couple of years ago. Knowing of my fondness for jazz, she went on eBay and bid for a black and white portrait of the great Miles Davis. The striking photo shows a very young Davis (perhaps in his early 20s at the time of the photo) with trumpet in hand and a music chart in front of him. He appears thoughtful and contemplative in the photo, as if he’s pondering where the next note will take him. The portrait of the late jazz innovator was used as part of an old Apple Computer ad campaign. The simply stated ad tagline in the top right-hand ... continue reading
    By Stacey Stefansky, DPM, Thanh L. Dinh, DPM, and Barry Rosenblum, DPM
    15,913 reads | 0 comments | 08/03/02
    Despite advances in aseptic technique and antibiotic prophylaxis, post-operative infections remain a significant complication following podiatric surgery. Postoperative infections can increase morbidity, lengthen recuperation time and compromise the success of a surgical procedure. Data collected by the Centers for Disease Control and Prevention (CDC) estimate that postoperative infections occur in 2.1 percent of all clean, uncontaminated surgical procedures.1 Studies pertaining specifically to podiatric surgery have produced comparable postoperative infection rates. Hugar, et. al., demonstr... continue reading
    Those who have used the Epos Ultra, which  has received FDA approval for treating plantar fasciitis, have cited favorable results.
    By Gina DiGironimo, Production Editor
    4,793 reads | 1 comments | 08/03/02
    Plantar fasciitis is a common condition that affects over 2.5 million Americans. If conservative treatments fail, podiatrists are exploring the merits of extracorporeal shock wave therapy (ESWT), a non-invasive procedure, before considering surgical options. ESWT received FDA approval in 2000 for the treatment of plantar fasciitis. Earlier this year, a new ESWT device called the Epos Ultra (which includes built-in ultrasound technology) received FDA approval for the plantar fasciitis indication. Those who have used the Epos Ultra have cited very favorable treatment results. Lowell Scott Weil... continue reading
    The Promogran Matrix Wound Dressing was recently granted FDA approval for the treatment of exuding wounds, including diabetic, venous and pressure ulcers.
    By Jeff Hall, Editor-in-Chief
    7,593 reads | 0 comments | 08/03/02
    What products are facilitating quicker wound healing? What are some of the cutting-edge devices that are generating interest among podiatrists? What antibiotics are getting results? Are there new innovations that can provide adjunctive relief in diabetic foot wounds? In an attempt to answer some of these questions, we talked to leading podiatrists in the field. Without further delay, here’s what they had to say. 1. Promogran Matrix Wound Dressing. This chronic wound dressing was recently granted FDA approval for the treatment of exuding wounds, including diabetic, venous and pressure... continue reading